ICPT Intercept Pharmaceuticals Inc.

108.01
-0.08  -0%
Previous Close 108.09
Open 107.12
Price To Book 33.44
Market Cap 3202979089
Shares 29,654,468
Volume 338,653
Short Ratio
Av. Daily Volume 464,749

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 3 trial to be initiated 1Q 2018.
Ocaliva - Obeticholic acid (OCA) - REVERSE
NASH patients with compensated cirrhosis
Phase 2 primary endpoint met - July 31, 2017. One patient death noted but DSMB noted unlikely to be related to OCA (company unsure).
Obeticholic acid (OCA) - CONTROL
NASH patients taking statins
Approved May 27 2016. Updated U.S. label for Ocaliva anticipated by early 2018
Obeticholic acid (Ocaliva)
Primary biliary cirrhosis (PBC) - POISE
Phase 3 data due 1H 2019.
Ocaliva (Obeticholic acid (OCA)) - REGENERATE
Adult nonalcoholic steatohepatitis (NASH) patients.
Phase 2 data released July 31, 2017 - primary endpoint met. Late breaker at AASLD October 23, 2017.
Obeticholic acid (OCA) AESOP
Primary Sclerosing Cholangitis (PSC)

Latest News

  1. The 10 Best Stocks to Buy to Finish Out 2018
  2. Today's Research Reports on Trending Tickers: Intercept Pharmaceuticals and Ultragenyx Pharmaceutical
  3. Better Buy: Intercept Pharmaceuticals vs. Genfit
  4. See what the IHS Markit Score report has to say about Intercept Pharmaceuticals Inc.
  5. Are Options Traders Betting on a Big Move in Intercept Pharmaceuticals (ICPT) Stock?
  6. Factors of Influence in 2018, Key Indicators and Opportunity within Caesars Entertainment, Intercept Pharmaceuticals, Exxon Mobil, Teligent, Amerco, and Mettler-Toledo International — New Research Emphasizes Economic Growth
  7. Why Is Intercept (ICPT) Up 4% Since Last Earnings Report?
  8. Why Acadia Pharmaceuticals Stock Rose 20.8% Yesterday
  9. Today's Research Reports on Trending Tickers: Intercept Pharmaceuticals and Amicus Therapeutics
  10. Intercept Pharmaceuticals Inc (ICPT) President & CEO Mark Pruzanski Sold $5.1 million of Shares
  11. Today's Research Reports on Trending Tickers: Intercept Pharmaceuticals and bluebird bio
  12. Why Viking Therapeutics Stock Is Bolting Higher Today
  13. 5 Pharma Stocks to Stay Away From
  14. Why Intercept Pharmaceuticals, Inc. Stock Broke Down in October
  15. Edited Transcript of ICPT earnings conference call or presentation 31-Oct-18 12:30pm GMT
  16. Today's Research Reports on Trending Tickers: Intercept Pharmaceuticals and Seattle Genetics
  17. Intercept (ICPT) Gains on Earnings and Revenue Beat in Q3